24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
18/06/2020
Eurecat, at the cutting edge of plastronics
03/06/2020
Barcelona will be connected to one of the longest subsea fiber optic cable in the world
20/05/2020
Hub B30: a useful platform
07/05/2020
We are a territory of innovation
16/04/2020
Alba synchrotron: the double life of electrons
02/04/2020
Alba synchrotron: 10 years at the service of the society